Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16285081 | 0.94 | ZDHHC20 (0.46) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD | |
| SCHEMBL6929537 | 0.88 | ZDHHC20 (0.43) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD | |
| SCHEMBL16285095 | 0.81 | ALDH1A1 (0.45) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD | |
| SCHEMBL5746411 | 0.81 | ZDHHC20 (0.46) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD | |
| SCHEMBL6931427 | 0.78 | ZDHHC20 (0.43) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD | |
| SCHEMBL16285076 | 0.77 | TSHR (0.50) | ZDHHC20ZDHHC2ALDH1A1TSHRRECQL | |
| SCHEMBL345353 | 0.77 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD | |
| SCHEMBL12433200 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRMAPK1HDAC1HDAC6 | |
| SCHEMBL4316811 | 0.76 | ZDHHC20 (0.41) | ZDHHC20ZDHHC2 | |
| SCHEMBL16285074 | 0.76 | ZDHHC20 (0.44) | ZDHHC20ZDHHC2ALDH1A1TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137644-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | MORITA MITSUNOBU (JP) | 2017-05-18 | — | — | US | disclosed |
| US-9593248-B2 | Ink, ink cartridge, ink jet recording device, ink jet ink printed matter, compound, and composition | RICOH COMPANY, LTD. (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | RICOH COMPANY, LTD. (JP) | 2014-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140363634-A1 | INK, INK CARTRIDGE, INK JET RECORDING DEVICE, INK JET INK PRINTED MATTER, COMPOUND, AND COMPOSITION | CDKN1A, MAPK9, SFRP1 | ZDHHC20 4289/4885ZDHHC2 4661/4885ALDH1A1 883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.